Healthcare -
Biotechnology - NASDAQ - US
$ 12.8
-0.467 %
$ 1.29 B
Market Cap
-13.2
P/E
DAWN - COST OF REVENUE
Cost of Revenue DAWN - Day One Biopharmaceuticals, Inc.
383 K
LAST VALUE
38.73%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR